{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T22:59:25Z","timestamp":1794265165345,"version":"4.9.0"},"reference-count":39,"publisher":"Cambridge University Press (CUP)","issue":"11","license":[{"start":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T00:00:00Z","timestamp":1709683200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":["cambridge.org"],"crossmark-restriction":true},"short-container-title":["Br J Nutr"],"published-print":{"date-parts":[[2024,6,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    It is inconclusive whether trimethylamine N-oxide (TMAO) and choline and related metabolites, namely trimethylamine (TMA),\n                    <jats:sc>l<\/jats:sc>\n                    -carnitine, betaine and dimethylglycine (DMG), are associated with non-alcoholic fatty liver disease (NAFLD). Our objective was to investigate these potential associations. Additionally, we sought to determine the mediating role of TMAO. In this 1:1 age- and sex-matched case\u2013control study, a total of 150 pairs comprising NAFLD cases and healthy controls were identified. According to the fully adjusted model, after the highest tertile was compared with the lowest tertile, the plasma TMAO concentration (OR = 2\u00b702 (95 % CI 1\u00b704, 3\u00b792);\n                    <jats:italic>P<\/jats:italic>\n                    trend = 0\u00b7003),\n                    <jats:sc>l<\/jats:sc>\n                    -carnitine concentration (OR = 1\u00b779 (1\u00b701, 3\u00b717);\n                    <jats:italic>P<\/jats:italic>\n                    trend = 0\u00b7020) and DMG concentration (OR = 1\u00b781 (1\u00b700, 3\u00b728);\n                    <jats:italic>P<\/jats:italic>\n                    trend = 0\u00b7014) were significantly positively associated with NAFLD incidence. However, a significantly negative association was found for plasma betaine (OR = 0. 50 (0\u00b728, 0\u00b788);\n                    <jats:italic>P<\/jats:italic>\n                    trend = 0\u00b7001). The restricted cubic splines model consistently indicated positive dose\u2013response relationships between exposure to TMAO,\n                    <jats:sc>l<\/jats:sc>\n                    -carnitine, and DMG and NAFLD risk, with a negative association being observed for betaine. The corresponding AUC increased significantly from 0\u00b7685 (0\u00b7626, 0\u00b7745) in the traditional risk factor model to 0\u00b7769 (0\u00b7716, 0\u00b7822) when TMAO and its precursors were included (\n                    <jats:sc>l<\/jats:sc>\n                    -carnitine, betaine and choline) (\n                    <jats:italic>P<\/jats:italic>\n                    = 0\u00b7032). Mediation analyses revealed that 14\u00b77 and 18\u00b76 % of the excess NAFLD risk associated with\n                    <jats:sc>l<\/jats:sc>\n                    -carnitine and DMG, respectively, was mediated by TMAO (the\n                    <jats:italic>P<\/jats:italic>\n                    values for the mediating effects were 0\u00b7021 and 0\u00b7036, respectively). These results suggest that a higher concentration of TMAO is associated with increased NAFLD risk among Chinese adults and provide evidence of the possible mediating role of TMAO.\n                  <\/jats:p>","DOI":"10.1017\/s0007114524000631","type":"journal-article","created":{"date-parts":[[2024,3,5]],"date-time":"2024-03-05T21:46:02Z","timestamp":1709675162000},"page":"1915-1923","update-policy":"https:\/\/doi.org\/10.1017\/policypage","source":"Crossref","is-referenced-by-count":38,"title":["Trimethylamine N-oxide, choline and its metabolites are associated with the risk of non-alcoholic fatty liver disease"],"prefix":"10.1017","volume":"131","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-8960-3159","authenticated-orcid":false,"given":"Rong","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangying","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2024,3,6]]},"reference":[{"key":"S0007114524000631_ref11","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1093\/ajcn\/nqac217","article-title":"The human gut microbiota and glucose metabolism: a scoping review of key bacteria and the potential role of SCFAs","volume":"116","author":"Palmn\u00e4s-B\u00e9dard","year":"2022","journal-title":"Am J Clin Nutr"},{"key":"S0007114524000631_ref39","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1440-1746.2010.06592.x","article-title":"Reactive oxygen and mechanisms of inflammatory liver injury: present concepts","volume":"26","author":"Jaeschke","year":"2011","journal-title":"J Gastroenterol Hepatol"},{"key":"S0007114524000631_ref6","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41575-020-0269-9","article-title":"Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders","volume":"17","author":"Aron-Wisnewsky","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"S0007114524000631_ref16","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.3390\/cells9041005","article-title":"Noninvasive diagnosis of NAFLD and NASH","volume":"9","author":"Piazzolla","year":"2020","journal-title":"Cells"},{"key":"S0007114524000631_ref27","doi-asserted-by":"crossref","first-page":"140","DOI":"10.5625\/lar.2018.34.4.140","article-title":"Crosstalk between FXR and TGR5 controls glucagon-like peptide 1 secretion to maintain glycemic homeostasis","volume":"34","author":"Kim","year":"2018","journal-title":"Lab Anim Res"},{"key":"S0007114524000631_ref21","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s13643-023-02238-w","article-title":"Efficacy and safety of carnitine supplementation on NAFLD: a systematic review and meta-analysis","volume":"12","author":"Liu","year":"2023","journal-title":"Syst Rev"},{"key":"S0007114524000631_ref14","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.3390\/nu10101513","article-title":"Dietary choline intake: current state of knowledge across the life cycle","volume":"10","author":"Wiedeman","year":"2018","journal-title":"Nutrients"},{"key":"S0007114524000631_ref33","doi-asserted-by":"crossref","first-page":"G1068","DOI":"10.1152\/ajpgi.00249.2010","article-title":"Betaine improves nonalcoholic fatty liver and associated hepatic insulin resistance: a potential mechanism for hepatoprotection by betaine","volume":"299","author":"Kathirvel","year":"2010","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"S0007114524000631_ref37","doi-asserted-by":"crossref","first-page":"6018","DOI":"10.1210\/en.2008-0816","article-title":"Fibroblast growth factor 21 corrects obesity in mice","volume":"149","author":"Coskun","year":"2008","journal-title":"Endocrinology"},{"key":"S0007114524000631_ref31","doi-asserted-by":"crossref","first-page":"5205126","DOI":"10.1155\/2018\/5205126","article-title":"Implications of the intestinal microbiota in diagnosing the progression of diabetes and the presence of cardiovascular complications","volume":"2018","author":"Leustean","year":"2018","journal-title":"J Diabetes Res"},{"key":"S0007114524000631_ref13","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.3390\/metabo12121243","article-title":"Trimethylamine N-oxide levels in non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"12","author":"Theofilis","year":"2022","journal-title":"Metabolites"},{"key":"S0007114524000631_ref5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"S0007114524000631_ref3","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1002\/hep.30702","article-title":"Unexpected rapid increase in the burden of NAFLD in China from 2008 to 2018: a systematic review and meta-analysis","volume":"70","author":"Zhou","year":"2019","journal-title":"Hepatology"},{"key":"S0007114524000631_ref19","doi-asserted-by":"crossref","first-page":"290","DOI":"10.2307\/270723","article-title":"Asymptotic confidence intervals for indirect effects in structural equation models","volume":"13","author":"Sobel","year":"1982","journal-title":"Sociol Methodol"},{"key":"S0007114524000631_ref9","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1093\/ajcn\/nqac074","article-title":"Gut microbiota-derived metabolite trimethylamine-N-oxide and multiple health outcomes: an umbrella review and updated meta-analysis","volume":"116","author":"Li","year":"2022","journal-title":"Am J Clin Nutr"},{"key":"S0007114524000631_ref18","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.3390\/nu10121971","article-title":"Trimethylamine-N-oxide (TMAO) as novel potential biomarker of early predictors of metabolic syndrome","volume":"10","author":"Barrea","year":"2018","journal-title":"Nutrients"},{"key":"S0007114524000631_ref26","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.jbiosc.2014.03.001","article-title":"Dietary trimethylamine N-oxide exacerbates impaired glucose tolerance in mice fed a high fat diet","volume":"118","author":"Gao","year":"2014","journal-title":"J Biosci Bioeng"},{"key":"S0007114524000631_ref28","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1002\/hep.29857","article-title":"Intestine farnesoid X receptor agonist and the gut microbiota activate G-protein bile acid receptor-1 signaling to improve metabolism","volume":"68","author":"Pathak","year":"2018","journal-title":"Hepatology"},{"key":"S0007114524000631_ref20","doi-asserted-by":"crossref","first-page":"364","DOI":"10.3390\/metabo12040364","article-title":"Flavin-containing monooxygenase 3 (FMO3) is critical for dioxin-induced reorganization of the gut microbiome and host insulin sensitivity","volume":"12","author":"Massey","year":"2022","journal-title":"Metabolites"},{"key":"S0007114524000631_ref22","doi-asserted-by":"crossref","first-page":"19076","DOI":"10.1038\/srep19076","article-title":"Associations of gut-flora-dependent metabolite trimethylamine-N-oxide, betaine and choline with non-alcoholic fatty liver disease in adults","volume":"6","author":"Chen","year":"2016","journal-title":"Sci Rep"},{"key":"S0007114524000631_ref25","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/S1665-2681(19)31821-6","article-title":"New insights into the pathophysiology of nonalcoholic fatty liver disease","volume":"8","author":"Chavez-Tapia","year":"2009","journal-title":"Ann Hepatol"},{"key":"S0007114524000631_ref10","first-page":"301","article-title":"Trimethylamine N-oxide (TMAO) in human health","volume":"20","author":"Gatarek","year":"2021","journal-title":"EXCLI J"},{"key":"S0007114524000631_ref2","doi-asserted-by":"crossref","unstructured":"2. Le, MH , Le, DM , Baez, TC , et al. (2023) Global incidence of non-alcoholic fatty liver disease: a systematic review and meta-analysis of 63 studies and 1\u00a0201\u00a0807 persons. J Hepatol 79, 287\u2013295.","DOI":"10.1016\/j.jhep.2023.03.040"},{"key":"S0007114524000631_ref24","doi-asserted-by":"crossref","first-page":"107401","DOI":"10.1016\/j.pharmthera.2019.107401","article-title":"The unfolded protein response and hepatic lipid metabolism in non alcoholic fatty liver disease","volume":"203","author":"Song","year":"2019","journal-title":"Pharmacol Ther"},{"key":"S0007114524000631_ref29","doi-asserted-by":"crossref","first-page":"10774","DOI":"10.1021\/acs.jafc.1c03077","article-title":"Understanding choline bioavailability and utilization: first step toward personalizing choline nutrition","volume":"69","author":"Goh","year":"2021","journal-title":"J Agric Food Chem"},{"key":"S0007114524000631_ref30","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.celrep.2017.06.039","article-title":"Microbial-host co-metabolites are prodromal markers predicting phenotypic heterogeneity in behavior, obesity, and impaired glucose tolerance","volume":"20","author":"Dumas","year":"2017","journal-title":"Cell Rep"},{"key":"S0007114524000631_ref36","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1017\/S0007114515001130","article-title":"Betaine alleviates hepatic lipid accumulation via enhancing hepatic lipid export and fatty acid oxidation in rats fed with a high-fat diet","volume":"113","author":"Xu","year":"2015","journal-title":"Br J Nutr"},{"key":"S0007114524000631_ref38","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1515\/cclm-2012-0518","article-title":"Metabolic crosstalk between choline\/1-carbon metabolism and energy homeostasis","volume":"51","author":"Zeisel","year":"2013","journal-title":"Clin Chem Lab Med"},{"key":"S0007114524000631_ref34","doi-asserted-by":"crossref","first-page":"G634","DOI":"10.1152\/ajpgi.00249.2009","article-title":"Betaine improved adipose tissue function in mice fed a high-fat diet: a mechanism for hepatoprotective effect of betaine in nonalcoholic fatty liver disease","volume":"298","author":"Wang","year":"2010","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"S0007114524000631_ref12","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s13668-020-00307-3","article-title":"Metabolites linking the gut microbiome with risk for type 2 diabetes","volume":"9","author":"Zhu","year":"2020","journal-title":"Curr Nutr Rep"},{"key":"S0007114524000631_ref15","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ab.2014.03.016","article-title":"Measurement of trimethylamine-N-oxide by stable isotope dilution liquid chromatography tandem mass spectrometry","volume":"455","author":"Wang","year":"2014","journal-title":"Anal Biochem"},{"key":"S0007114524000631_ref8","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11883-021-00910-x","article-title":"Trimethylamine N-oxide (TMAO), diet and cardiovascular disease","volume":"23","author":"Thomas","year":"2021","journal-title":"Curr Atheroscler Rep"},{"key":"S0007114524000631_ref4","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41575-020-00381-6","article-title":"Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention","volume":"18","author":"Huang","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"S0007114524000631_ref7","doi-asserted-by":"crossref","first-page":"5214","DOI":"10.3390\/ijms21155214","article-title":"Gut microbiota metabolites in NAFLD pathogenesis and therapeutic implications","volume":"21","author":"Chen","year":"2020","journal-title":"Int J Mol Sci"},{"key":"S0007114524000631_ref1","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.jhep.2023.04.036","article-title":"Changing epidemiology, global trends and implications for outcomes of NAFLD","volume":"79","author":"Wai-Sun Wong","year":"2023","journal-title":"J Hepatol"},{"key":"S0007114524000631_ref17","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1148\/radiol.12120896","article-title":"Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis","volume":"267","author":"Tang","year":"2013","journal-title":"Radiology"},{"key":"S0007114524000631_ref23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbrc.2022.01.060","article-title":"Changes of flavin-containing monooxygenases and trimethylamine-N-oxide may be involved in the promotion of non-alcoholic fatty liver disease by intestinal microbiota metabolite trimethylamine","volume":"594","author":"Shi","year":"2022","journal-title":"Biochem Biophys Res Commun"},{"key":"S0007114524000631_ref32","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1039\/C4FO01073F","article-title":"Myricetin derived from Hovenia dulcis Thunb. Ameliorates vascular endothelial dysfunction and liver injury in high choline-fed mice","volume":"6","author":"Guo","year":"2015","journal-title":"Food Funct"},{"key":"S0007114524000631_ref35","doi-asserted-by":"crossref","first-page":"G894","DOI":"10.1152\/ajpgi.00133.2007","article-title":"Involvement of AMP-activated protein kinase in beneficial effects of betaine on high-sucrose diet-induced hepatic steatosis","volume":"293","author":"Song","year":"2007","journal-title":"Am J Physiol Gastrointest Liver Physiol"}],"updated-by":[{"DOI":"10.1017\/s0007114524000928","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T00:00:00Z","timestamp":1709683200000}}],"container-title":["British Journal of Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0007114524000631","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T08:20:39Z","timestamp":1716452439000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0007114524000631\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,6]]},"references-count":39,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,6,14]]}},"alternative-id":["S0007114524000631"],"URL":"https:\/\/doi.org\/10.1017\/s0007114524000631","relation":{},"ISSN":["0007-1145","1475-2662"],"issn-type":[{"value":"0007-1145","type":"print"},{"value":"1475-2662","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,6]]},"assertion":[{"value":"\u00a9 The Author(s), 2024. Published by Cambridge University Press on behalf of The Nutrition Society","name":"copyright","label":"Copyright","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}}]}}